Clinical trial · Interventional

The Addition of Dexmedetomidine on Postoperative Sleep for Middle-aged and Elderly Patients With Gastric Cancer

The Addition of Dexmedetomidine on Postoperative Sleep for Middle-aged and Elderly Patients With Gastric Cancer: A Prospective Randomized Clinical Trial

NCT03117023CI-TRIAL-00027015unknownPhase 3ClinicalTrials.gov clinicaltrialsPublishedExplore in graph →

Summary

Brief summary (as posted)

The purpose of this study is to find out the effect of Dexmedetomidine for treatment of sleep deprivation, pain relief and postoperative recovery on middle-aged and elderly Patients with Gastric Cancer.

Conditions

Conditions (1)

Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.

Condition (as posted)	Mapped entity	Match	Confidence
Gastric Cancer	Malignant Gastric Neoplasm	CURATED_BROADER	0.80

Interventions

Interventions (1)

Intervention	Type	Mapped drug	Match
dexmedetomidine	Drug	—	UNRESOLVED

Design

Arms and outcomes

Arms (2)

type
EXPERIMENTAL
label
dexmedetomidine group
description
sufentanil + dexmedetomidine
interventionNames
1. Drug: dexmedetomidine
type
NO_INTERVENTION
label
control group
description
sufentanil + saline

Primary outcomes (1)

measure
sleep time
timeFrame
during the first three days after surgery
description
total sleep time during the first three days after surgery

Secondary outcomes (5)

Eligibility

Eligibility (as posted)

Sex: All
Minimum age: 55 Years

Show eligibility criteria text

Inclusion Criteria:

Elective gastric cancer operation Age ≧ 55 years ASA classification：I to III, BMI: 18-30 kg/m2 without the history of gastrointestinal surgery the normal coagulation function -

Exclusion Criteria:

the history of gastrointestinal surgery Gastrostomy and jejunostomy sleep apnea syndrome or severe osahs Severe liver and heart dysfunction Severe mental illness

\-

References

Publications (0)

Data not yet available

No reference posted for this study.